176 related articles for article (PubMed ID: 30325974)
41. Plasma miR-21 is a novel diagnostic biomarker for biliary tract cancer.
Kishimoto T; Eguchi H; Nagano H; Kobayashi S; Akita H; Hama N; Wada H; Kawamoto K; Tomokuni A; Tomimaru Y; Umeshita K; Doki Y; Mori M
Cancer Sci; 2013 Dec; 104(12):1626-31. PubMed ID: 24118467
[TBL] [Abstract][Full Text] [Related]
42. Oncogenic KRAS-expressing organoids with biliary epithelial stem cell properties give rise to biliary tract cancer in mice.
Kasuga A; Semba T; Sato R; Nobusue H; Sugihara E; Takaishi H; Kanai T; Saya H; Arima Y
Cancer Sci; 2021 May; 112(5):1822-1838. PubMed ID: 33068050
[TBL] [Abstract][Full Text] [Related]
43. Prognostic Value of Carbohydrate Antigen 19-9 and the Surgical Margin in Extrahepatic Cholangiocarcinoma.
Yamamoto R; Sugiura T; Ashida R; Ohgi K; Yamada M; Otsuka S; Uesaka K
Ann Gastroenterol Surg; 2022 Mar; 6(2):307-315. PubMed ID: 35261957
[TBL] [Abstract][Full Text] [Related]
44. Movement of a novel serum tumour marker, RCAS1, in patients with biliary diseases.
Enjoji M; Yamaguchi K; Nakamuta M; Nakashima M; Kotoh K; Tanaka M; Nawata H; Watanabe T
Dig Liver Dis; 2004 Sep; 36(9):622-7. PubMed ID: 15460847
[TBL] [Abstract][Full Text] [Related]
45. A Panel of Novel Detection and Prognostic Methylated DNA Markers in Primary Non-Small Cell Lung Cancer and Serum DNA.
Ooki A; Maleki Z; Tsay JJ; Goparaju C; Brait M; Turaga N; Nam HS; Rom WN; Pass HI; Sidransky D; Guerrero-Preston R; Hoque MO
Clin Cancer Res; 2017 Nov; 23(22):7141-7152. PubMed ID: 28855354
[No Abstract] [Full Text] [Related]
46. A combination of serum leucine-rich α-2-glycoprotein 1, CA19-9 and interleukin-6 differentiate biliary tract cancer from benign biliary strictures.
Sandanayake NS; Sinclair J; Andreola F; Chapman MH; Xue A; Webster GJ; Clarkson A; Gill A; Norton ID; Smith RC; Timms JF; Pereira SP
Br J Cancer; 2011 Oct; 105(9):1370-8. PubMed ID: 21970875
[TBL] [Abstract][Full Text] [Related]
47. Analysis of the methylation of CpG islands in the
Maekawa H; Ito T; Orita H; Kushida T; Sakurada M; Sato K; Hulbert A; Brock MV
Oncol Lett; 2020 Mar; 19(3):2197-2204. PubMed ID: 32194717
[TBL] [Abstract][Full Text] [Related]
48. Comparison of Inflammation-based Prognostic Scores in Patients With Biliary Tract Cancer After Surgical Resection.
Utsumi M; Kitada K; Tokunaga N; Yoshida Y; Narusaka T; Hamano R; Miyasou H; Tsunemitsu Y; Otsuka S; Inagaki M
Anticancer Res; 2021 Apr; 41(4):2147-2155. PubMed ID: 33813426
[TBL] [Abstract][Full Text] [Related]
49. Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients.
Balgkouranidou I; Matthaios D; Karayiannakis A; Bolanaki H; Michailidis P; Xenidis N; Amarantidis K; Chelis L; Trypsianis G; Chatzaki E; Lianidou ES; Kakolyris S
Mutat Res; 2015 Aug; 778():46-51. PubMed ID: 26073472
[TBL] [Abstract][Full Text] [Related]
50. Human G-protein gamma 7 in extrahepatic cholangiocarcinoma and its clinicopathological significance.
Wang M; Gong B; Li Y; Wang Y
Hematol Oncol Stem Cell Ther; 2010; 3(2):66-70. PubMed ID: 20543539
[TBL] [Abstract][Full Text] [Related]
51. Can preoperative and postoperative CA19-9 levels predict survival and early recurrence in patients with resectable hilar cholangiocarcinoma?
Wang JK; Hu HJ; Shrestha A; Ma WJ; Yang Q; Liu F; Cheng NS; Li FY
Oncotarget; 2017 Jul; 8(28):45335-45344. PubMed ID: 28484084
[TBL] [Abstract][Full Text] [Related]
52. Relationship between S100A4 protein expression and pre-operative serum CA19.9 levels in pancreatic carcinoma and its prognostic significance.
Jia F; Liu M; Li X; Zhang F; Yue S; Liu J
World J Surg Oncol; 2019 Sep; 17(1):163. PubMed ID: 31526392
[TBL] [Abstract][Full Text] [Related]
53. Prognostic relevance of preoperative bilirubin-adjusted serum carbohydrate antigen 19-9 in a multicenter subset analysis of 179 patients with distal cholangiocarcinoma.
Bolm L; Petrova E; Weitz J; Rückert F; Wittel UA; Makowiec F; Lapshyn H; Bronsert P; Rau BM; Khatkov IE; Bausch D; Keck T; Wellner UF; Distler M
HPB (Oxford); 2019 Nov; 21(11):1513-1519. PubMed ID: 30956162
[TBL] [Abstract][Full Text] [Related]
54. Preoperative serum CA19-9 levels is an independent prognostic factor in patients with resected hilar cholangiocarcinoma.
Cai WK; Lin JJ; He GH; Wang H; Lu JH; Yang GS
Int J Clin Exp Pathol; 2014; 7(11):7890-8. PubMed ID: 25550829
[TBL] [Abstract][Full Text] [Related]
55. Global alterations of DNA methylation in cholangiocarcinoma target the Wnt signaling pathway.
Goeppert B; Konermann C; Schmidt CR; Bogatyrova O; Geiselhart L; Ernst C; Gu L; Becker N; Zucknick M; Mehrabi A; Hafezi M; Klauschen F; Stenzinger A; Warth A; Breuhahn K; Renner M; Weichert W; Schirmacher P; Plass C; Weichenhan D
Hepatology; 2014 Feb; 59(2):544-54. PubMed ID: 24002901
[TBL] [Abstract][Full Text] [Related]
56. Predictive Significance of Promoter DNA Methylation of
Kubota Y; Tanabe S; Azuma M; Horio K; Fujiyama Y; Soeno T; Furue Y; Wada T; Watanabe A; Ishido K; Katada C; Yamashita K; Koizumi W; Kusano C
J Gastric Cancer; 2021 Dec; 21(4):379-391. PubMed ID: 35079440
[TBL] [Abstract][Full Text] [Related]
57. DLEC1 methylation is associated with a better clinical outcome in patients with intrahepatic cholangiocarcinoma of the small duct subtype.
Kim Y; Lee K; Jeong S; Wen X; Cho NY; Kang GH
Virchows Arch; 2019 Jul; 475(1):49-58. PubMed ID: 30610381
[TBL] [Abstract][Full Text] [Related]
58. DNA methylation level of OPCML and SFRP1: a potential diagnostic biomarker of cholangiocarcinoma.
Amornpisutt R; Proungvitaya S; Jearanaikoon P; Limpaiboon T
Tumour Biol; 2015 Jul; 36(7):4973-8. PubMed ID: 25652468
[TBL] [Abstract][Full Text] [Related]
59. Tumoral LINE-1 hypomethylation is associated with poor survival of patients with intrahepatic cholangiocarcinoma.
Jeong S; Lee K; Wen X; Kim Y; Cho NY; Jang JJ; Kang GH
BMC Cancer; 2017 Aug; 17(1):588. PubMed ID: 28851390
[TBL] [Abstract][Full Text] [Related]
60. DJ-1 is a useful biomarker for invasive extrahepatic cholangiocarcinoma.
Tabata Y; Nakanishi Y; Hatanaka KC; Hatanaka Y; Tsuchikawa T; Okamura K; Noji T; Shichinohe T; Matsuno Y; Hirano S
Hum Pathol; 2018 Jun; 76():28-36. PubMed ID: 29447925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
